Longeveron Inc. (LGVN) - Dilution Analysis

10-Q filing | 29.7M shares outstanding

10-K filing | 21.8M shares outstanding

8-K filing: The company filed a Certificate of Designation for Series A Non-Voting Convertible Preferred Stock and is issuing up to 26,975 authorized shares in a Private Placement.

10-Q filing | 13.7M shares outstanding

S-1/A filing: Longeveron is offering up to 3,846,154 shares of Class A common stock and Class A common warrants to fund clinical and regulatory development of laromestrocel.

10-Q filing | 13.5M shares outstanding

S-3 filing: This S-3 filing indicates Longeveron Inc. may offer and sell up to $70,000,000 in various securities, including Class A Common Stock and Preferred Stock, subject to completion, as detailed in the prospectus supplement.

10-K filing | 13.5M shares outstanding

10-Q filing | 13.4M shares outstanding

10-Q filing | 12.9M shares outstanding

S-1 filing: This prospectus relates to the re-sale or other disposition from time to time by certain selling stockholders identified herein of up to 2,565,392 shares of our Class A Common Stock issuable upon the exercise of certain warrants held by the Selling Stockholders.

S-1 filing: This S-1 filing registers the resale of Class A common stock issuable upon exercise of June private placement warrants held by selling stockholders. The filing also discloses the shares of Class A and Class B common stock outstanding.

S-1/A filing: This prospectus relates to the re-sale or other disposition from time to time by certain selling stockholders of up to 4,967,470 shares of our Class A Common Stock issuable upon the exercise of certain warrants held by the Selling Stockholders.

10-Q filing | 4.9M shares outstanding

S-1 filing: This prospectus relates to the re-sale or other disposition from time to time by certain selling stockholders of up to 4,967,470 shares of our Class A Common Stock issuable upon the exercise of certain warrants held by the Selling Stockholders.

S-1/A filing: This prospectus relates to the re-sale or other disposition from time to time by certain selling stockholders identified herein (each, a "Selling Stockholder" and, together, the "Selling Stockholders") or their pledgees, assignees, distributees and successors-in-interest, from time to time, of up to of up to 145,020 shares of our Class A Common Stock, par value $0.001 per share ("Class A common stock") issuable upon the exercise of certain warrants held by the Selling Stockholders (including shares that may be issued to the holder in lieu of fractional shares).

S-1/A filing: This S-1/A filing registers shares of Class A common stock and Class A common warrants for sale, along with shares issuable upon exercise of the warrants, to fund clinical development, regulatory approvals, capital expenditures, and working capital.

S-1/A filing: This S-1/A filing registers shares of Class A common stock and Class A common warrants for purchase.

8-K filing: Stock split 1-for-10 | Outstanding: 1,029,461 → 102,946

S-1 filing: This S-1 filing describes an offering of Class A common stock and Class A common warrants, or pre-funded warrants and warrants, along with a reverse stock split at a ratio of 1:10 effective March 26, 2024.

10-K filing | 10.3M shares outstanding

S-1 filing: This prospectus relates to the re-sale or other disposition from time to time by certain selling stockholders identified herein of up to 1,450,172 shares of our Class A Common Stock issuable upon the exercise of certain warrants held by the Selling Stockholders.

S-1 filing: This S-1 filing registers the resale of up to 5,018,183 shares of Class A Common Stock issuable upon the exercise of warrants held by selling stockholders.

10-Q filing | 8.9M shares outstanding

8-K filing: Longeveron Inc. completed a rights offering, receiving subscriptions for shares of Class A common stock at $3.00 per share, with gross proceeds expected to be approximately $325,000. ($0.33M proceeds)

8-K filing: Longeveron Inc. entered into a Dealer-Manager Agreement with R.F. Lafferty & Co., Inc. for a rights offering of up to $30.0 million of its Class A common stock at a $3.00 subscription price per share. ($30.0M proceeds)

S-1/A filing: The company is distributing transferable subscription rights to purchase up to $30.0 million of Class A common stock to holders of common stock and warrants, with each right entitling the holder to purchase one share of Class A common stock for $3.00 per share.

10-Q filing | 6.3M shares outstanding

S-1/A filing: Longeveron is conducting a rights offering to raise capital for clinical trials and general corporate purposes, distributing transferable subscription rights to purchase Class A common stock to existing shareholders and warrant holders, with R.F. Lafferty acting as the dealer-manager and placement agent for unsubscribed shares.

S-1 filing: The company is conducting a rights offering to raise capital for clinical trials and general corporate purposes, distributing transferable subscription rights to purchase Class A common stock to existing shareholders and warrant holders.

10-Q filing | 6.2M shares outstanding

10-K filing | 6.2M shares outstanding

10-Q filing | 6.1M shares outstanding

10-Q filing | 5.9M shares outstanding

10-Q filing | 5.4M shares outstanding

S-3 filing: Longeveron Inc. is offering common stock, preferred stock, warrants, purchase contracts and units in one or more offerings up to an aggregate offering price of $50,000,000.

10-K filing | 5.3M shares outstanding

S-1 filing: The company sold Class A common stock in multiple offerings, including an IPO, an over-allotment exercise, and a PIPE offering involving common stock and warrants.

10-Q filing | 3.4M shares outstanding

10-Q filing | 3.4M shares outstanding

10-Q filing | 3.3M shares outstanding

S-1/A filing: The company is offering 2,272,727 shares of Class A common stock in its initial public offering, with an expected price between $10.00 and $12.00 per share. They are also issuing warrants to the underwriter, Kingswood Capital Market, to purchase up to 4.0% of the total number of shares of Class A common stock being sold in this offering.

S-1/A filing: The company is offering 2,272,727 shares of Class A common stock in its initial public offering, with an expected price between $10.00 and $12.00 per share and is offering warrants to the underwriter to purchase up to 4.0% of the total number of shares of Class A common stock being sold in this offering.

S-1/A filing: This S-1/A filing relates to a proposed public offering of Class A Common Stock with underwriter warrants exercisable for Class A Common Stock. Kingswood Capital Markets is the underwriter.

S-1 filing: The filing is for an initial public offering of Class A common stock.